Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
72,742.01
(
-0.33%
)
News Focus
News Focus
Post# of 821030
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dennisdave

Send PM Follow Ignore
Followers 43
Posts 5340
Boards Moderated 0
Alias Born 12/05/2021

dennisdave

Re: H2R post# 747193

Monday, 02/03/2025 11:50:32 AM

Monday, February 03, 2025 11:50:32 AM

Post# of 821030
DCVax-L is not an mRNA therapy – It is a personalized dendritic cell-based cancer vaccine, meaning it does not fall under the scope of this consultation, which focuses on mRNA-based therapies. If anything. The fact that MHRA is proactively addressing regulatory pathways for novel cancer treatments indicates a general willingness to support innovative therapies like DCVax-L.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News